Integrating enhanced hepatitis C testing and counselling in research.
Rebecca Winter, Oanh Nguyen, Peter Higgs, Stuart Armstrong, Duyen Duong, My Li Thach, Campbell Aitken, Margaret Hellard
Int J Drug Policy | Published : 2008
The hepatitis C virus (HCV) affects over 170 million people worldwide. In Australia, over 225,000 people have been diagnosed with HCV infection with 13,000 infections reported annually; 90% are attributed to injecting drug use. Burnet Institute (BI) researchers have been studying the HCV epidemic since the virus was identified in 1989 including community based cohort studies (1990-1995), numerous studies involving Vietnamese-Australian people who inject drugs (PWID) (1996-2004) and social network studies (2000-2002, 2005-2007). Through this work the BI has developed a model of research practice for HCV and PWID, developed in recognition that much research relating to BBV infections - and HCV..View full abstract